Numbers of People with HIV/AIDS Reported and Not Reported to Surveillance in Japan

BACKGROUND: Trends in the numbers of Japanese patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) reported to the HIV/AIDS surveillance system in Japan were examined. We attempted to estimate the cumulative number of Japanese with HIV, including people with HIV not reported to the surveillance. METHODS: Data from the HIV/AIDS surveillance in Japan up to the end of 2002 were available. The number of unreported HIV cases was estimated using the back-calculation method. To evaluate this method, the number of reported HIV cases up to 1996 (before highly active antiretroviral treatments were widely available in Japan) was compared with the number estimated by the same method. RESULTS: The number of AIDS cases who were initially reported as having AIDS without having been reported as HIV-infected markedly increased as did the number of reported HIV cases. The number of AIDS cases who had been initially reported as HIV-infected and who were then reported as AIDS progression increased up to 1996 but decreased in the period of 1997-2002. The cumulative number of people with HIV at the end of 2002 was estimated as 14,000, which was 4.2 times higher than the number of reported HIV cases. The cumulative number of HIV cases reported up to 1996 was nearly equal to the number estimated by the above-mentioned method. CONCLUSIONS: HIV infection would appear to be spreading widely among Japanese population. The number of HIV cases actually reported to surveillance might still be low.

[1]  S. Hashimoto,et al.  Survey of Physicians Working for AIDS Core Hospitals about Reporting on HIV Infected Persons and AIDS Patients and the Factors That May Influence the Decision to Report , 2003 .

[2]  M. Feldman,et al.  Introduction: HIV/AIDS surveillance in a new era. , 2003, Journal of Acquired Immune Deficiency Syndromes.

[3]  Shuji Hashimoto,et al.  HIV/AIDS Surveillance in Japan, 1984‐2000 , 2003, Journal of acquired immune deficiency syndromes.

[4]  Neff Walker,et al.  HIV Surveillance: A Global Perspective , 2003, Journal of acquired immune deficiency syndromes.

[5]  S. Oka,et al.  Physical condition and activity of daily living among HIV patients infected through blood products in Japan. , 2002, Journal of epidemiology.

[6]  Y. Matsuyama,et al.  Attempt at Long-term Prediction of the Numbers of HIV-infected Persons and AIDS Cases in Japan Using System Analysis , 2002 .

[7]  Y. Matsuyama,et al.  Future Prediction of the Number of HIV-infected Persons and AIDS Cases , 2000 .

[8]  Y. Matsuyama,et al.  Delays and continuation of hospital visits among HIV-infected persons and AIDS cases in Japan. , 2000, Journal of epidemiology.

[9]  Y. Matsuyama,et al.  Trends in HIV and AIDS based on HIV/AIDS surveillance data in Japan. , 1999, International journal of epidemiology.

[10]  Calvin Cohen,et al.  Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease , 1998, The Lancet.

[11]  R. Hogg,et al.  Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. , 1998, JAMA.

[12]  C Maurath,et al.  Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. , 1998, Lancet.

[13]  M A Fischl,et al.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. , 1997, The New England journal of medicine.

[14]  T. Umeda HIV/AIDS Situation in Japan , 1996 .

[15]  S. Lwanga,et al.  Estimation and projection of adult AIDS cases: a simple epidemiological model. , 1991, Bulletin of the World Health Organization.

[16]  Ron Brookmeyer,et al.  MINIMUM SIZE OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) EPIDEMIC IN THE UNITED STATES , 1986, The Lancet.

[17]  A. Morley,et al.  Cyclic leucocytosis as evidence for retention of normal homoeostatic control in chronic granulocytic leukaemia. , 1967, Lancet.